| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 07/17/2003 | US20030134430 Novel amino acid sequences for human caenorhabditis elegans-like protein polypeptides |
| 07/17/2003 | US20030134414 Ligating a peripheral nerve, then excising material rich in glial cells, providing a support matrix and inserting into spinal cords |
| 07/17/2003 | US20030134400 Isolation of genes that encode enzymes (Delta 4-desaturase) involved in the conversion of adrenic acid to omega 6-docosapentaenoic acid and omega 3-docosapentaenoic acid to docosahexaenoic acid |
| 07/17/2003 | US20030134390 An isolated polynucleotide molecule encoding an IL-21 antagonist polypeptide of specefic amino acid sequence; culturing |
| 07/17/2003 | US20030134389 A polypeptide identified as fibroblast growth factor/heparin binding growth factor referred to as FGF-13 for promoting wound healing, to prevent neuronal damage associated with stroke, skin aging and to stimulate angiosenesis |
| 07/17/2003 | US20030134387 Vertebrate globin |
| 07/17/2003 | US20030134385 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 07/17/2003 | US20030134384 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 07/17/2003 | US20030134383 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 07/17/2003 | US20030134382 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 07/17/2003 | US20030134381 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 07/17/2003 | US20030134380 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 07/17/2003 | US20030134379 Nucleic acid molecule comprising a nucleotide sequence that encodes a PRO polypeptide |
| 07/17/2003 | US20030134378 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 07/17/2003 | US20030134377 Nucleic acid molecule comprising a nucleotide sequence that encodes a PRO polypeptide |
| 07/17/2003 | US20030134376 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 07/17/2003 | US20030134375 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 07/17/2003 | US20030134374 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 07/17/2003 | US20030134373 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 07/17/2003 | US20030134372 Nucleic acid molecule comprising a nucleotide sequence that encodes a PRO polypeptide |
| 07/17/2003 | US20030134370 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 07/17/2003 | US20030134369 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 07/17/2003 | US20030134368 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 07/17/2003 | US20030134367 Vectors with DNA encoding pro polypeptides |
| 07/17/2003 | US20030134366 Vectors with DNA encoding pro polypeptides |
| 07/17/2003 | US20030134365 Vectors with DNA encoding pro polypeptides |
| 07/17/2003 | US20030134364 Vectors with DNA encoding pro polypeptides |
| 07/17/2003 | US20030134363 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 07/17/2003 | US20030134362 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 07/17/2003 | US20030134361 Vectors with DNA encoding pro polypeptides |
| 07/17/2003 | US20030134360 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 07/17/2003 | US20030134359 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 07/17/2003 | US20030134358 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 07/17/2003 | US20030134357 Vectors with DNA encoding pro polypeptides |
| 07/17/2003 | US20030134356 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 07/17/2003 | US20030134355 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 07/17/2003 | US20030134354 Vectors with DNA encoding pro polypeptides |
| 07/17/2003 | US20030134350 Zinc finger domain recognition code and uses thereof |
| 07/17/2003 | US20030134344 Her2 gene amplification as detected by fluorescence in situ hybridization |
| 07/17/2003 | US20030134342 Binding-specific peptides, binding-specific carrier molecules, and uses thereof |
| 07/17/2003 | US20030134335 Method for reducing the immunogenicity of heterologous proteins by elimination of t-cell epitopes |
| 07/17/2003 | US20030134327 Polypeptides fused to heterologous polypeptide sequences, antibodies which bind these polypeptides |
| 07/17/2003 | US20030134314 Assaying the ability of specific polypeptide activity, thereby identifying a compound capable of treating a hematologic disorder |
| 07/17/2003 | US20030134308 Bone morphogenic proteins (BMP), BMP receptors and BMP binding proteins and their use in the diagnosis and treatment of glaucoma |
| 07/17/2003 | US20030134306 Human and murine cytokine polypeptides |
| 07/17/2003 | US20030134301 Nucleic acids, their expression products and pathways involved in pain, and their use in screening for molecule that can alleviate pain |
| 07/17/2003 | US20030134297 Uses of DC-SIGN and DC-SIGNR for inhibiting hepatitis C virus infection |
| 07/17/2003 | US20030134284 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 07/17/2003 | US20030134282 Quantitative analysis of tissue gene expression; amplification; polymerase chain reaction |
| 07/17/2003 | US20030134266 Methods of screening for compounds that modulate blood vessel formation |
| 07/17/2003 | US20030133995 Neutralizing amount of casein protein, or salt thereof, alkali earth metal halide, water; to neutralize effect of capsaicin on oral cavity, tongue, and esophagus |
| 07/17/2003 | US20030133989 Skin care products containing whole egg |
| 07/17/2003 | US20030133984 Comprising poorly water soluble drug, solubilizing component, and surfactant which is semisolid or solid; drug may e.g. be a cyclosporin or a macrolide; immunosuppressants |
| 07/17/2003 | US20030133980 Biocompatible polymer blends and uses thereof |
| 07/17/2003 | US20030133979 Device for the sustained release of aggregation-stabilized, biologically active agent |
| 07/17/2003 | US20030133971 Positively charged and neutral lipids facilitates cellular uptake; liposomes |
| 07/17/2003 | US20030133964 Polymeric delivery formulations of leuprolide with improved efficacy |
| 07/17/2003 | US20030133953 Complexing a biologically active agent with a perturbant to reversibly transform and exposing a membrane or bilayer to the supramolecular complex |
| 07/17/2003 | US20030133950 Inducing a desired T helper lymphocyte regulated immune response by delivering an immunogen to a preselected region of the gastrointestinal tract of a patient |
| 07/17/2003 | US20030133938 Antibody-avidin fusion proteins as cytotoxic drugs |
| 07/17/2003 | US20030133937 Incubating the biological preparation with a saccharide, a glycoconjugate or an antibody that inhibits the binding of malignant cells expressing sialyl Lea or di-sialyl Lea, to endothelial cells expressing a LEC-CAM (selectin) |
| 07/17/2003 | US20030133936 Modulating glucocorticoid induced tumor necrosis factor receptor (GITR) with an agent (antibody, a small molecular agonist antagonist antibodies) that binds GITR to potentiate regulatory T cell function |
| 07/17/2003 | US20030133935 Administering to the human an effective (tumor necrosis factor)TNF- inhibiting amount of an anti-TNF chimeric antibody, which competitively inhibits binding of TNF to monoclonal antibody cA2 |
| 07/17/2003 | US20030133933 Novel integrin alpha subunit |
| 07/17/2003 | US20030133930 Administering to a patient having an autoimmune disorder an antibody to a B-cell antigens and a carrier; CD22, CD20, CD19, and CD74 or HLA-DR antigen. |
| 07/17/2003 | US20030133927 Conjugates useful in the treatment of prostate cancer |
| 07/17/2003 | US20030133926 Reducing the exposure to the food containing gluten and casein, administering a microbial tyrosinase or a phenylalaninase and a proline peptidase with foods |
| 07/17/2003 | US20030133925 Monobactam compositions and methods of use thereof |
| 07/17/2003 | US20030133924 Highly phosphorylated acid beta-glucocerebrosidase and methods of treating gaucher's disease |
| 07/17/2003 | US20030133923 Composition for preventing the formation and enhancing the breakdown of bezoars in animals and humans |
| 07/17/2003 | US20030133919 An immunogene therapy for treating diseases associated with excessive interleukin-18 induced immunoreaction; administering a transfected cells, preventing autoimmune and allergic disease |
| 07/17/2003 | US20030133912 Receptor-targeted adenoviral vectors |
| 07/17/2003 | US20030133911 Pneumovirus ns proteins antagonising the interferon (ifn) response |
| 07/17/2003 | US20030133910 Inhibiting cell proliferation by administering a large dosage of wild-type ras proteins |
| 07/17/2003 | US20030133908 Treatment for intracranial tumors |
| 07/17/2003 | US20030133907 Amino acid sequence for treating lung diseases, such as idiopathic pulmonary fibrosis |
| 07/17/2003 | US20030133906 Administering interleukin-10 (IL-10), side effect reduction from other diseases |
| 07/17/2003 | US20030133879 Therapeutic composition for pulmonary delivery |
| 07/17/2003 | DE20302861U1 Bio-compatible electrode, for in vivo electroporation, comprises a hydrogel coating as a barrier between electrochemical reactions and the biological target |
| 07/17/2003 | CA2767061A1 Specific binding agents of human angiopoietin-2 |
| 07/17/2003 | CA2475173A1 Use of amylin agonists to modulate triglycerides |
| 07/17/2003 | CA2472937A1 Use of p97 as an enzyme delivery system for the delivery of therapeutic lysosomal enzymes |
| 07/17/2003 | CA2472927A1 A novel splice variant of myd88 and uses thereof |
| 07/17/2003 | CA2472882A1 Modification of feeding behavior |
| 07/17/2003 | CA2472647A1 Mammal prolactin variants |
| 07/17/2003 | CA2472633A1 S-dimethylarsino-thiosuccinic acid s-dimethylarsino-2-thiobenzoic acid s-(dimethylarsino) glutathione as treatments for cancer |
| 07/17/2003 | CA2472617A1 Substituted amino carboxamides for the treatment of alzheimer's disease |
| 07/17/2003 | CA2472575A1 Hair removal and animal husbandry method |
| 07/17/2003 | CA2472282A1 Gene products differentially expressed in cancerous breast cells and their methods of use |
| 07/17/2003 | CA2472180A1 Hair follicle growth |
| 07/17/2003 | CA2472118A1 Pak5-related compositions and methods |
| 07/17/2003 | CA2472049A1 Dominant negative proteins and methods thereof |
| 07/17/2003 | CA2471972A1 Proteases producing an altered immunological response and methods of making and using the same |
| 07/17/2003 | CA2471957A1 Cyclic tetrapeptide compound and use thereof |
| 07/17/2003 | CA2471947A1 Methods for therapeutic use of brain derived neurotrophic factor in the entorhinal cortex |
| 07/17/2003 | CA2471868A1 Methods of generating multispecific, multivalent agents from vh and vl domains |
| 07/17/2003 | CA2471768A1 Body weight gain inhibitor |
| 07/17/2003 | CA2471750A1 Polyphenol inhibition of nucleoside diphosphate kinase-b activity and cancer metastasis |
| 07/17/2003 | CA2471719A1 Method of treating apoptosis and compositions thereof |
| 07/17/2003 | CA2471530A1 Systems and methods for the analysis of protein phosphorylation |